Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers are working with schools around the county to find 24,000 volunteers aged 16 to 18 years to take part in the Be on the TEAM (Teenagers Against Meningitis) trial, led by the Oxford Vaccine Group at the Oxford University's Paediatrics Department with funding and support from the National Institute for Health Research (NIHR).

Photo credit: Meningitis Research Foundation.

The NHS is inviting teenagers to join the fight against meningitis by taking part in a study to see whether giving a group B meningococcal (MenB) vaccine to teenagers reduces carriage of this bacteria in their throat, potentially providing protection to all ages from this dangerous infection.

Bacteria in the throat can cause meningitis (inflammation of the membranes that surround the brain) and septicaemia (blood poisoning), both of which can be fatal or cause long lasting damage. The age groups most at risk of meningitis are babies, pre-school children and teenagers. 

Find out more (Department of Paediatrics website)

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.